News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Active Biotech AB Release: Patent Application Submitted Regarding The Mode Of Action For Quinoline Compounds
March 27, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The candidate drugs within the laquinimod, 57-57 and TASQ projects all belong to a chemical group called quinolines. The exact mode of action for quinoline compounds has so far not been defined.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
September 9, 2026
·
2 min read
·
Nick Paul Taylor
Insights
Can Benelux turn scientific strength into larger biotech scale?
September 8, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
·
5 min read
·
Angela Gabriel
Startups
10 life sciences startups selected for accelerator program
September 4, 2026
·
2 min read
·
Angela Gabriel